Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hang Qian

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Medicine Insights. Oncology|October 23, 2023
Evaluating the Role of Morphological Parameters in the Prostate Transition Zone in PHI-Based Predictive Models for Detecting Gray Zone Prostate CancerYu-Hang Qian, Yun-Tian Shi, Xu-Jun Sheng, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|August 10, 2025
[Diagnostic performance of PI-RADS v2.1 for clinically significant prostate cancer in the peripheral, transitional and multiple zones]Xiao-Jun Deng, Hao-Cheng Zhang, Jiong Zhang, et al.
Biomarker Research|August 23, 2025
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancerFu-Hao Ji, Yu-Hang Qian, Xiu-Chen Guo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Medicine Insights. Oncology|October 23, 2023
Evaluating the Role of Morphological Parameters in the Prostate Transition Zone in PHI-Based Predictive Models for Detecting Gray Zone Prostate CancerYu-Hang Qian, Yun-Tian Shi, Xu-Jun Sheng, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|August 10, 2025
[Diagnostic performance of PI-RADS v2.1 for clinically significant prostate cancer in the peripheral, transitional and multiple zones]Xiao-Jun Deng, Hao-Cheng Zhang, Jiong Zhang, et al.
Biomarker Research|August 23, 2025
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancerFu-Hao Ji, Yu-Hang Qian, Xiu-Chen Guo, et al.
Pageof 1